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Abstract
Protein phosphorylation plays a key role in many cellular processes but there is presently no 
accurate information or reliable procedure to determine the relative abundance of many 
phosphoamino acids in cells. At pH ≤ 8, phosphohistidine is unstable compared to the 
extensively studied phosphoserine, phosphothreonine and phosphotyrosine.  This study 
reports the absolute quantitative analysis of histidine phosphorylation of proteins from a 
human bronchial epithelial cell (16HBE14o-) lysate using 31P NMR spectroscopic analysis. 
The method was designed to minimize loss of the phosphohistidine phosphoryl group. 
Phosphohistidine was determined on average to be approximately one third as abundant as 
phosphoserine and phosphothreonine combined (and thus roughly 20 times more abundant 
than phosphotyrosine). The amount of phosphohistidine, and 
phosphoserine/phosphothreonine per gram of protein from a cell lysate was determined to be 
23 µmol/g and 68 µmol/g respectively. The amount of phosphohistidine, and 
phosphoserine/phosphothreonine per cell was determined to be 1.8 fmol/cell, and 5.8 
fmol/cell respectively. After tryptic digest of proteins from the16HBE14o- cell lysate, the 
phosphohistidine signal was abolished and increasing phosphoserine/phosphothreonine signal 
was observed, which has implications for mass spectrometry investigations. The 31P NMR 
spectroscopic analysis not only highlights the abundance of phosphohistidine, which likely 
reflects its importance in mammalian cells, but also provides a way of measuring and 
comparing levels of phosphorylated amino acids in cells. 
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Introduction 
Phosphorylation is one of the most common post-translational modifications (PTMs)1 and is 
involved in a vast number of cellular processes in many life forms. There are thought to be 
nine phosphorylated amino acid residues in nature: phosphoserine (pSer), phosphothreonine 
(pThr), phosphotyrosine (pTyr), phosphohistidine (pHis),2 phospholysine (pLys),3 
phosphoarginine (pArg),3 phosphoaspartic acid (pAsp),4 phosphoglutamic acid (pGlu),4 and 
phosphocysteine (pCys).5 From a molecular perspective, phosphorylation of an amino acid 
residue results in a change in charge (the phosphoryl group exists mostly as a dianion under 
physiological conditions6) and thus a change in the surface potential of a protein.7 At the 
cellular level this can be considered a large change, and mis-regulated phosphorylation can be 
detrimental to biological function.8, 9 
The existence of phosphorylated amino acid residues diversifies the role of phosphorylation 
in biology as each phosphorylated amino acid residue has different chemical properties. For 
example, the oxygen-phosphorus linked amino acids (pSer, pThr and pTyr) are relatively acid 
stable compared to the acid labile nitrogen-linked phosphoramidate (pHis, pLys, pArg), 
carboxy oxygen-linked acyl phosphate (pAsp, pGlu), and sulfur-linked phosphorthiolate 
(pCys).5, 10 Routinely used amino acid analysis methods employ acidic conditions10 which 
can destroy acid labile phosphorylation. Therefore, it is not surprising that pSer, pThr, and 
pTyr currently dominate the “Proteome Wide PTM Statistics Curator”1 and 
“PhosphoSitePlus”11 phosphorylation statistics, suggesting that acid labile phosphorylated 
amino acids are not as abundant or important and have largely not been detected (and may 
therefore have been neglected).1 To date the majority of protein phosphorylation research 
(especially in mammalian cells) has been focused on pSer, pThr and pTyr.  
There is clear evidence for histidine (His) phosphorylation in nature,2 and mass spectrometry 
(MS) studies by Hardman et al. on HeLa cells12 and Potel et al. on E. coli13 suggest pHis may 
be more widespread in both eukaryotes and prokaryotes than previously thought. Unlike 
other phosphorylated amino acid residues, there are two isomers of pHis, namely τ-pHis and 
π-pHis (Supplementary Fig. S1).  Several reviews have addressed the role of pHis in cells and 
conventional wisdom considers pHis as a high energy intermediate in the transfer of the 
phosphoryl group in intermediate or central metabolism and cell signalling.2, 14-16 However, 
there may be other roles of pHis in biology that have not yet been discovered. Therefore, the 
question remains as to how abundant is pHis (and other phosphorylated amino acids) in cells?
Determining the abundance of pHis and other phosphorylated amino acids in a cell lysate 
using MS is problematic. Depending on the precise conditions used in the MS analysis, there 
is a tendency for the phosphoryl group either to be lost before detection of the phosphorylated 
peptide or for it to transfer to another amino acid residue giving rise to false positives.17-20 In 
addition, as with other amino acid analysis methods such as Edman degradation, hydrolysis, 
and MS, samples are subjected to many potentially destructive and prolonged downstream 
steps which use acidic conditions either in sample preparation or in analysis. For example, in 
MS analysis of peptides, samples typically undergo overnight trypsinization (37 ºC, pH 8),  
desalting (acidic pH) and HPLC (acidic pH) before analysis.21 Such conditions decompose 
acid labile phosphorylated amino acids such as pHis.2, 22 
In this study, 31P NMR spectroscopy is introduced as a simple and direct detection method in 
the absolute quantification of pHis (and other phosphorylated amino acids) in a mammalian 
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whole cell lysate, using the human bronchial epithelial cell line (16HBE14o- or HBE). The 
method is simple and involves minimal sample handling, and on average pHis was found to 
be much more abundant than previously thought: one third as abundant as pSer and pThr 
combined, strongly implying an important functional role for pHis in eukaryotic cells. The 
procedure is likely applicable for the absolute quantification of phosphorylated amino acids 
in other cells.
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To address the question of how abundant pHis is in a mammalian cell using 31P NMR 
spectroscopy, it was first important to determine the regions in which pHis signals typically 
appear in a 31P NMR spectrum. τ-pHis and π-pHis were synthesized by the reaction of His 
with potassium phosphoramidate in water to allow determination of reference 31P chemical 
shifts of each isomer.23 Chemical shifts of - 4.99 ppm and - 5.76 ppm were observed for τ-
pHis and π-pHis respectively (Supplementary Fig. S2a and b), entirely consistent with those 
previously reported.23, 24 To establish proof of concept and to identify 31P NMR chemical 
shifts characteristic of pHis in a protein environment under conditions that could be used to 
analyze proteins from a cell lysate, it was important to establish a protein standard. MS 
studies have shown that myoglobin can be phosphorylated selectively on His residues using 
potassium phosphoramidate in water to give myoglobin-pHis (Myo-pHis).12, 25 Potassium 
phosphoramidate was used to phosphorylate myoglobin in water, at 25 ºC for 15 h.25 pHis is 
more stable under basic conditions (pH 10-12), and unstable under neutral and acidic 
conditions,26 and therefore Myo-pHis was buffer exchanged into 0.1 M Na2CO3/NaHCO3, at 
pH 10.8 (which also removed any unreacted potassium phosphoramidate), and subsequently 
concentrated and analyzed by 31P NMR spectroscopy.  Multiple pHis residue signals were 
observed in the chemical shift range of - 4.40 to - 5.76 ppm (Fig. 1aii); additionally an 
inorganic phosphate (Pi) signal at 2.57 ppm and a signal at 8.27 ppm which was characteristic 
of pLys 27 (later confirmed by HMBC, see Fig. 1c) were also observed.
Figure 1. 31P NMR spectra of Myo-pHis. ai) Myoglobin (17.7 mg/mL) in 91 mM Na2CO3/NaHCO3, 10 % 
(v/v) D2O, pH 10.8; aii) Myo-pHis (17.7 mg/mL) in 91 mM Na2CO3/NaHCO3, 10 % (v/v) D2O, pH 10.8. 
Myoglobin was phosphorylated with potassium phosphoramidate, was buffer exchanged into 0.1 M 
Na2CO3/NaHCO3, pH 10.8 and concentrated; aiii) Myo-pHis (13.8 mg/mL) in 71 mM Na2CO3/NaHCO3, 6.4 M 
urea, 10 % (v/v), D2O, pH 10.8. The Myo-pHis sample used was the same sample as Fig. 1aii. Note the 
Na2CO3/NaHCO3, and Myo-pHis concentration changed because of the addition of urea; b) HMBC NMR 
spectrum of Myo-pHis, sample Fig. 1aiii; ci) Myo-pHis (18.2 mg/mL) in 91 mM Na2CO3/NaHCO3, 10 % (v/v) 
D2O, pH 10.8, prepared as Fig. 1aii; cii) Myo-pHis after treatment with 1/50 (wt/wt) trypsin, at 37 °C for 16 h in 
0.1 M NH4HCO3, pH 8.0. Na2CO3, NaHCO3 and D2O was subsequently added before 31P NMR spectroscopic 
analysis, ciii) Myo-pHis in 91 mM Na2CO3/NaHCO3, 10 % (v/v) D2O, pH 10.8 after trypsinisation and 




/NaHCO3, 10 % (v/v) D2O, pH 10.8, 
prepared as Fig. 1aii; dii) Myo-pHis after reduction with DTT (3 mmol), alkylation with IAA (14 mmol) and 
subsequent treatment with 2 % (wt/wt) trypsin, at 30 °C for 16 h in 0.1 M NH4HCO3, pH 8.0. Na2CO3, NaHCO3 
and D2O was subsequently added before 31P NMR spectroscopic analysis; diii) Myo-pHis in 91 mM 
Na2CO3/NaHCO3, 10 % (v/v) D2O, pH 10.8, after trypsinization and subsequent desalting
To reduce the tertiary structural effect of myoglobin on the pHis chemical shifts, Myo-pHis 
was treated with a denaturant, 7 M urea (Fig. 1aiii). Two distinct sets of signals in the ranges 
- 4.80 to - 5.38 ppm, and - 5.52 to - 5.98 ppm were observed in the 31P NMR spectrum of the 
denatured Myo-pHis. In heteronuclear multiple bond correlation (HMBC) NMR experiments 
of denatured Myo-pHis, cross peaks between 1H NMR aromatic protons and 31P NMR pHis 
residue signals are observed confirming phosphorylation had indeed occurred on His residues 
(Fig. 1b). On Western blots of Myo-pHis against commercially available pHis, pSer, pThr, 
and pTyr antibodies (Supplementary Fig. 3), no pSer, pThr, and pTyr residues were detected 
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which is in agreement with the 31P NMR spectrum (Fig. 1) and reported MS data for Myo-
pHis.12, 25  Furthermore, after acid treatment (~ pH 4) and heating (90 °C) of Myo-pHis, pHis 
and pLys residue signals were abolished, giving rise to an increased Pi signal suggesting the 
presence of acid labile residues (Supplementary Fig 4). pHis isomer distinction in a folded 
protein or peptide cannot always be made by comparing the pHis residue 31P NMR chemical 
shifts with pHis amino acid standards.28 However, comparison of the denatured Myo-pHis 
chemical shift regions of ~ - 4.94 ppm (major) and ~ - 5.61 ppm (minor) with the chemical 
shifts of τ-pHis and π-pHis amino acid standards (Supplementary Fig. S2a and b), suggests 
that the major pHis isomer in Myo-pHis was τ-pHis. τ-pHis is the more stable isomer of 
pHis26 and under conditions used to phosphorylate His, τ-pHis would be expected to be the 
major isomer present in Myo-pHis. 
To determine the number of pHis residues in the sample, a capillary tube containing an 
external standard (triphenylphosphine oxide, 10 mol % Cr(acac)3 in CDCl3) was used as an 
insert into the NMR tube containing Myo-pHis. Triphenylphosphine oxide was chosen as the 
external standard because it is a stable compound with a chemical shift ~ 30 ppm away from 
the pHis chemical shift region (Supplementary Fig. S5). The average number of pHis 
residues per myoglobin protein was determined to be 5.6 and the amount of pHis residues per 
gram of myoglobin was determined to be 0.32 mmol/g (Supplementary Fig. S5 for 
calculations). There are eleven His residues in myoglobin, all of which have been observed 
by MS to be phosphorylated by potassium phosphoramidate,25 and the quantitation here 
would suggest on average approximately half of His residues are phosphorylated. However, 
potassium phosphoramidate can phosphorylate both His imidazole nitrogens, and this 
possibility cannot be excluded for Myo-pHis.23 
Trypsinization and desalting are typical steps used to process proteins from a cell lysate 
before MS analysis, and the conditions used are likely to result in the destruction of some 
pHis. To assess the impact of trypsinization conditions, Myo-pHis was trypsinized using 
typical conditions (37 °C,  pH 8.0, 16 h)21 and then analyzed by 31P NMR spectroscopy (Fig. 
1c). There was a significant change in the integration ratio of Pi and pHis residue signals 
from 1:15.8 for Myo-pHis (Fig. 1ci), to 1:0.97 for trypsinised Myo-pHis (Fig. 1ci). In 
addition, pLys residue signals also decreased. These results show extensive hydrolysis of 
both pHis and pLys residues under typical trypsinization conditions. The trypsin treated Myo-
pHis (Fig. 1cii) was subsequently desalted using C-18 resin following typical acidic 
conditions.  In the 31P NMR spectrum of the desalted sample no pHis residue signals were 
observed suggesting desalting also has a destructive effect on pHis residues (Figure 1ciii).22 
Hardman et al. have detected Myo-pHis peptides by MS using milder trypsinization (Myo-
pHis was first treated with dithiothreitol, and then iodoacetamide before the addition of 
trypsin at 30 °C, pH 8.0, 16 h) and desalting conditions (neutral solutions).12 Under these 
trypsinization conditions, the 31P NMR spectra (Fig. 1di and dii) integration ratios of Pi and 
pHis residue signals changed from 1:15.8 for Myo-pHis to 1:1.35 for trypsinized Myo-pHis 
showing a modest reduction in the amount of pHis residues that were hydrolyzed compared 
to typical trypsinization condition (vide supra). Following Hardman et al., Myo-pHis treated 
with trypsin was desalted using a C-18 resin and neutral solutions. The sample was 
subsequently analyzed by 31P NMR spectroscopy (Fig. 1diii). Relatively small pHis residue 
signals were observed when compared to the spectrum of Myo-pHis treated with trypsin (Fig. 
1dii).  The 31P NMR data shows that even using milder trypsinization and desalting 
conditions there was a significant loss of pHis. 
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Quantitation of pHis in mammalian cells
The quantitative 31P NMR spectroscopic analysis of pHis residues developed on Myo-pHis 
was then applied to a more complex sample, namely the proteins from a cell lysate. Airway 
epithelia express His phosphorylated proteins and the 16HBE14o- cell line is a well-known 
airway epithelial cell line.29, 30 A Western blot of 16HBE14o- cell lysate using a pHis, 
antibody (ab2317090) detected several pHis bands confirming the presence of pHis residues 
(Fig. 2). Western blot and cell lysis procedures used pHis stabilizing conditions (see 
Methods). The pHis antibody selectivity was validated by acid treatment of the 16HBE14o- 
cell lysate which reduced the pHis signal, while base treatment retained the pHis signal 
(Supplementary Fig. S6). Similarly, Western blots of 16HBE14o- using pTyr, pThr, and pSer 
antibodies confirmed the presence of pTyr, pThr and pSer residues (Fig. 2). 
Figure 2. Western blot of 16HBE14o- cell lysates probed with phosphoantibodies. 16HBE14o- cell lysate 
(100 µg of protein) was probed with either pHis (ab2317090), pTyr (pY99), pThr, or pSer (Q5) antibody.
To analyze the 31P NMR signals (specifically arising from pHis residues) of phosphoproteins 
from 16HBE14o- cell lysates, it was important to use a procedure that removed other 
phosphorus containing molecules (e.g. nucleoside triphosphates, oligonucleotides etc.) and as 
much DNA/RNA as possible, which could otherwise potentially dominate the 31P NMR 
spectrum. It was also important to keep the solution alkaline at all times, because pHis is 
degraded rapidly in acidic or neutral conditions. The preferred buffer was a weak base (such 
as Na2CO3/NaHCO3, pH 10.8, vide supra) because pSer and pThr are known to decompose 
by β-elimination on overnight treatment with a strong base (1 M NaOH, 37 ºC).2, 31 Under 
these conditions, both pSer and pThr were found to be stable for more than two days 
(Supplementary Fig. S7a and b). Therefore, a robust, rapid and simple procedure was 
developed for preserving the native phosphorylation states. 
Lysis buffers containing urea as the denaturant have been used to prepare cell lysates for MS 
analysis of pHis.12, 13, 32 Thus, 16HBE14o- cells were lysed on culture plates using 0.1 M 
Na2CO3/NaHCO3, 7 M urea, pH 10.8 and were immediately subjected to sonication. 
Sonication breaks DNA into small pieces which are subsequently removed along with other 
phosphorus containing small molecules during buffer exchange (Supplementary Fig. S8), 
while the denaturant ensures that there is reduced or no enzymatic activity. Using this 
procedure, pHis and pSer/pThr33, 34 residue signals in the 31P NMR spectrum were 
reproducibly observed (Fig. 3) Additional chemical shift signals from -0.05 to -1.70 ppm 
were also observed in Fig 3. The chemical shift regions in which these signals are present are 
characteristic of orthophosphate diesters,35  and thus have been assigned accordingly. In the 
basal state, the expected abundance of pTyr residues in 16HBE14o- cells is low36 and 
observable 31P NMR pTyr  residue signals were not expected. Under the conditions used, 
pTyr is stable37 and is expected to have a chemical shift around 0.29 ppm (Supplementary 
Fig.S2e), but could not be assigned because any pTyr residue signals would overlap with 
signals due to orthophosphates.
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Figure 3. 31P NMR spectrum of proteins from the 16HBE14o- cell lysate. Proteins from the 16HBE14o- cell 
lysate (15.6 mg/mL) in 91 mM Na2CO3/NaHCO3, 6.4 M urea, 10 % (v/v) D2O, pH 10.8. 16HBE14o- cells were 
lysed on ice in 0.1 M Na2CO3/NaHCO3, 7 M urea, pH 10.8. The sample was immediately sonicated, buffer 
exchanged into 0.1 M Na2CO3/NaHCO3, 7 M urea, pH 10.8, and concentrated. pSer and pThr signal 
assignments have been made using literature chemical shift values.33, 34 †DNA, RNA, phospholipids.35
An alternative DNA removal strategy described by Antonioli et al.  that uses basic conditions 
to extract DNA, but precipitates the cell lysate proteins rather than keeping them in solution, 
was explored.38 Application of this method to the 16HBE14o- cell lysate (lysed in 30 mM 
Tris-HCl, 50 mM NaCl, complete protease inhibitor, pH 9.0) and subsequent 31P NMR 
spectroscopic analysis showed signals characteristic of orthophosphate diesters and 
pSer/pThr residues but no signals characteristic of pHis residues (Fig. 4a). Using protein 
precipitation conditions which have been previously used in the analysis of pHis by MS gave 
similar results (Fig 4b).13 Thus, it appears that protein precipitation is not beneficial in the 
analysis of pHis proteins from a cell lysate by 31P NMR spectroscopy. 
In order to explore the wider applicability of this method, Jurkat cells were analyzed by 
Western blots and 31P NMR spectroscopy. Western blots of Jurkat cell lysate confirmed the 
presence of pHis, pTyr, pSer and pThr (Supplementary Fig. S9a). However, unlike the 31P 
NMR spectrum of the proteins from the 16HBE14o- cell lysate, there were no observable 
pHis residue signals in the 31P NMR spectrum of the proteins from the Jurkat cell lysate 
(Supplementary Fig. S9b) but there were signals for pSer/pThr residues. Proteins from both 
the Jurkat and 16HBE14o- cell lysate were lysed, and buffer exchanged identically. Since the 
pHis residue signals are only observed in the 31P NMR spectrum of the proteins from the 
16HBE14o- cell lysate, this suggests that the abundance of pHis at the basal state can vary 
between different cell types, and that there may be different functional roles of pHis in 
different cell types.
Figure 4. 31P NMR spectra of proteins from 16HBE14o- cell lysate prepared by protein precipitation. a) 
Proteins from 16HBE14o- cell lysate in 91 mM Na2CO3/NaHCO3, 7.3 M urea, 10 % (v/v) D2O, pH 10.8. 
16HBE14o- cells were lysed on ice in 30 mM Tris-HCl, 50 mM NaCl, complete protease inhibitor, pH 9.0.and 
the DNA was extracted following Antonioli et al.38 The precipitated protein was dissolved and buffer exchanged 
into 0.1 M Na2CO3/NaHCO3 8 M urea, pH 10.8; b) Proteins from 16HBE14o- cell lysate in 91 mM 
Na2CO3/NaHCO3, 6.4 M urea, 10 % (v/v) D2O, pH 10.8. 16HBE14o- cells were lysed on ice in 0.1 M 
Na2CO3/NaHCO3, 7 M urea, pH 10.8, sonicated and the proteins were precipitated following Potel et al.13 pSer 
and pThr signal assignments have been made using literature chemical shift values.33, 34 †DNA, RNA, 
phospholipids.35 
For additional validation, the proteins from the 16HBE14o- cell lysate analyzed in Fig. 4a 
were chemically phosphorylated with potassium phosphoramidate which gave rise to 31P 
NMR signals from - 4.68 to - 6.13 ppm (Supplementary Fig. S10), confirming the signals 
observed in Fig. 3 are indeed pHis residues. Furthermore, as observed with Myo-pHis, acid 
treatment (~ pH 4) and heating (90 °C) of the proteins from the 16HBE14o- cell lysate 
resulted in loss of the pHis residue signals whilst giving rise to a Pi signal (Supplementary 
Fig. S11). Previously, relative phosphorylated amino acid abundances have been reported for 
proteins from a cell sample either as a percentage or ratio.39 However, since absolute 
quantitation is possible with 31P NMR spectroscopy (see Preliminary experiments), it is 
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possible to determine the absolute amounts of different phosphorylated amino acid residues, 
as well as the relative amounts.  In a triplicate 31P NMR spectroscopy analysis, 
pHis:pSer/pThr residue signal integration ratio was found to be on average 0.34:1 
(Supplementary Fig. S12). Using an external standard, the average amounts of pHis, and 
pSer/pThr residues per mass of protein cell lysate were determined to be 23 µmol/g, and 68 
µmol/g respectively (Supplementary Table S1). The amounts of pHis, and pSer/Thr residues 
per cell were determined to be 1.8 fmol/cell, and 5.8 fmol/cell respectively (Supplementary 
Table S2).
Figure 5. Quantification of pHis, pSer/pThr and polyphosphate using 31P NMR spectroscopy. a) The 
amounts of pHis, and pSer/pThr per gram of protein from 16HBE14o- cell lysate determined using 31P NMR 
spectroscopy; error bars show the standard error of the mean (n = 3); b) The amounts of pHis, and pSer/pThr per 
16HBE14o- cell determined using 31P NMR spectroscopy; error bars show the standard error of the mean (n = 
3).
As observed with the Myo-pHis standard, the intensities of the 31P NMR signals assigned to 
pHis residues were found to reduce upon trypsinization (Fig. 6a). However, unlike Myo-pHis, 
new signals from 19.06 to 20.38 ppm (phosphonate region of the spectrum) in the 31P NMR 
spectrum of trypsinised proteins from the 16HBE14o- cell lysate were observed but no Pi 
signal. Phosphonates contain a phosphorus-carbon bond and such bonds are likely to arise 
from the reaction of a nucleophilic carbon species and phosphate electrophile. However, the 
mechanism by which these phosphonates arise and their identity is unclear but previous 
studies have observed phosphonate lipids giving similar chemical shift values.40 Since high 
urea concentration reduces trypsin activity,21 the 16HBE14o- cell lysates were buffer 
exchanged in preparation for trypsinization. It is likely during this step that enzymatic activity 
in the 16HBE14o- cell lysates was restored to some extent. Whether the emergence of the 
phosphonate signals and absence of Pi signal was due to a chemical or enzymatic transfer of 
the phosphoryl group is again unclear. In-solution-trypsinization for MS sample preparations 
generally use cell lysates that have not been dialyzed but have undergone reduction and 
alkylation under denaturing conditions, after which the denaturant is diluted, and the sample 
is treated with trypsin.12, 41 For simplicity, and to minimize sample handling, reduction and 
alkylation was not carried out. After desalting, the phosphonate signals were absent, which 
suggests that they are either labile under the desalting conditions used or have been removed 
during desalting. Noticeably, pSer/pThr residue signals appeared to have gradually increased 
after trypsinization and desalting, and the orthophosphate diester signals have decreased. The 
presence of the orthophosphate diester signals after the desalt suggests these orthophosphate 
diesters are covalently linked to proteins, which is not uncommon.42  For comparison 
purposes (see Preliminary results), proteins from the 16HBE14o- cell lysate were trypsinized 
and desalted following conditions by Hardman et al., which included reduction and alkylation 
steps. A 31P NMR spectrum similar to Fig. 6iii was observed (Supplementary Fig. S14).12
Figure 6. 31P NMR spectra of proteins from 16HBE14o- cell lysate after trypsinization and desalting. i) 
Proteins from the 16HBE14o- cell lysate in 91 mM Na2CO3/NaHCO3, 6.4 M urea, 10 % (v/v) D2O, pH 10.8 
prepared as Fig. 3; ii) sample Fig. 6i after treatment with 1/50 (wt/wt) trypsin, at 37 °C for 16 h in 0.1 M 
NH4HCO3, pH 8.0. Na2CO3, NaHCO3 and D2O was subsequently added before 31P NMR spectroscopic analysis; 
iii) sample Fig. 6ii in 91 mM Na2CO3/NaHCO3, 10 % (v/v) D2O, pH 10.8, after desalting.; Signal assignments 
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have been made using literature chemical shift values.33-35, 43 †DNA, RNA, phospholipids.35 ‡New signals not 
present in Fig. 6i.
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Discussion
The study demonstrates unexpectedly high amounts of pHis in mammalian16HBE14o- cells. 
The study also suggests that pHis in cells may have previously gone undetected due to its 
labile nature under acidic and near neutral pH experimental conditions. By using a pHis 
stabilizing denaturing lysis buffer, and minimal sample processing steps followed by an 
upstream nondestructive analysis technique (i.e. 31P NMR spectroscopy), the amount of pHis 
residues was determined to be on average approximately one third the amount of pSer/pThr 
residues combined in proteins from the 16HBE14o- cell lysate. It is generally considered that 
the relative abundance of pSer, pThr and pTyr is approximately 83:15:1.5 in human cells,44 
implying that pHis is likely to be about 20 times more abundant in human cells than pTyr 
(consistent with the results shown here), and that it is therefore likely to have hitherto 
unexplored functions. Finally, on subjecting proteins from the 16HBE14o- cell lysate to 
trypsinization, the 31P NMR pHis residue signals were abolished (Fig. 6) along with  
increased pSer/pThr residue signals, suggesting that some possible enzymatic or chemical 
transfer of phosphate from pHis or orthophosphate diesters to pSer/pThr may occur after cell 
lysis, providing a mechanism for potential false positives in phosphoproteomic experiments, 
especially under non-denaturing conditions. 
The study demonstrates that 31P NMR spectroscopy can be applied to the absolute 
quantitation of pHis (and other phosphoamino acids) in a mammalian cell. The study also 
shows that 31P NMR spectroscopy can be used as a tool to monitor changes in 
phosphorylation resulting from subjecting a sample to different conditions. The simplicity of 
the procedure (only three sample processing steps before spectroscopic analysis: lysis, 
sonication, and simultaneous buffer exchange/concentration) highlights the potential broad 
applicability of the method in phosphoamino acid residue analyses of various cells/tissues or 
even small multicellular organisms. Since absolute quantitation is possible with 31P NMR 
spectroscopy, phosphorylation can be expressed in moles per gram of protein cell lysate or 
per cell, thereby allowing direct comparison between different cells or cell types. 
Importantly, subjecting pHis-containing samples to trypsinization and desalting results in loss 
of pHis which has potential implication for MS sample preparations (Fig. 1 and 6). The 
artifactual increase of pSer/pThr following sample manipulation in cell lysates, shown in Fig. 
6, is an interesting and surprising finding and suggests chemical or enzymatic transfer of 
phosphorus species. As such, it may be possible that the basal state abundances of pSer and 
pThr in cells may be significantly lower than currently recorded. Though the precise 
mechanism and importance of pHis phosphoryl transfer to serine (Ser) or threonine (Thr) 
residues are presently unclear, observations exist in the literature of in vitro Ser 
phosphorylation of kinase suppressor of Ras (KSR) in the presence of His kinase via 
nm23/NDPK, suggesting a potential His-to-Ser protein kinase pathway.45 
Nevertheless, using a pHis stabilizing denaturing lysis buffer, the 31P NMR spectrum in Fig. 
3 shows that, at the basal state, pHis residues are more abundant in mammalian 16HBE14o- 
cells than previously thought. Until now Ser, Thr and Tyr phosphorylated amino acid 
residues in mammalian cells have been thought to be the major players in cell signaling. 
However, pHis may also be a major player in cell signaling. And though pHis is known to be 
involved in bacterial cell signaling,2 the roles of pHis in mammalian cells, and pHis proteins, 
.CC-BY 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in 
The copyright holder for thisthis version posted December 3, 2020. ; https://doi.org/10.1101/2020.12.03.409540doi: bioRxiv preprint 
13
their function, and associated (potential) kinases and phosphatases remain largely unknown.14 
Genetic approaches in prokaryotes and lower eukaryotes revealed pHis residues are important 
in two-component signaling systems.9 The absence of corresponding vertebrate homologs of 
the two-component signaling systems led to the notion that perhaps pHis is predominantly a 
non-vertebrate cellular and signaling intermediate. This notwithstanding, a full 
characterization of pHis function in prokaryotes and lower eukaryotes also remains to be 
done; for example, an accurate abundance of pHis in non-vertebrate cells is still unclear. 
Hitherto, there was no procedure or method to provide practical insight to such key questions. 
One can speculate that pHis abundance relates to important mammalian cell requirements and 
cellular processes including cell signaling, immune system, energy 
stores/metabolism/homeostasis, and gene transcription/ regulation. One example of the 
importance of pHis is illustrated by the need to relay nascent ATP away from the outer rim of 
the mitochondrion to avoid negative charge build up such that energy production is 
compromised if phosphorylated histidine is unavailable.46 For example, mutation of NME3, a 
member of the NDPK family, underlies a fatal mitochondrial disorder,47 and double deletion 
of murine NME1 and NME2 is incompatible with postnatal life.48 It is possible that the high 
levels of pHis seen here are merely a consequence of the high levels of histidine and 
phosphate carriers in the cell, and have no biological implications. However, Nature tends to 
make use of such chemical opportunities, as witnessed in bacterial two-component signaling 
systems; and the observation of specific histidine-targeted phosphotransferases15 strongly 
implies a functional role.
In conclusion, this study introduces a 31P NMR spectroscopy method for absolute 
quantification of pHis and pSer/pThr in mammalian cells, thereby in principle allowing direct 
comparison between different cell types. This simple, direct method has allowed a 
longstanding question about the likely importance of pHis in mammalian cell biology to be 
addressed by demonstrating for the first time that pHis is a relatively abundant 
phosphorylation PTM in 16HBE14o- cells under basal conditions. 
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Methods
Quantitative 31P NMR spectroscopy of proteins. 
Norell® Standard Series™ 5 mm NMR tubes length 7 inches, inner diameter 4.2 mm were 
used. 31P spectra were acquired on a Bruker AVANCE III or Bruker AVANCE III HD 
spectrometer at 162.0MHz or 202.5MHz respectively. Data were acquired using an 
acquisition window of 9.69 kHz or 12.1 kHz respectively (59.9 ppm) with 32 k acquisition 
points (14-15 hours acquisition time), a 30 pulse and a relaxation delay of 8s. This pulse 
angle and recycle delay combination had previously been determined to be sufficiently long 
for complete relaxation, thus quantitative for all 31P containing species in the samples, 
including those with external standard which was doped with chromium(III) acetylacetonate 
to aid relaxation. 
External standard 
Norell® high throughput 3mm NMR sampling tubes length 203 mm, inner diameter 2.41 mm 
were used as the external standard capillary. The capillary contained 2 or 4 mM 
triphenylphosphine oxide, 10 mol % chromium(III) acetylacetonate, dissolved in 150 µL of 
deuterated chloroform (CDCl3). 
1H-31P HMBC spectroscopy
1H-31P HMBC spectra were acquired on a Bruker AVANCE III 400 spectrometer, using 1664 
scans for each of 128 increments over an acquisition window of 9.7 kHz and 3.6 kHz (2 k 
points) in F1 and F2 respectively and optimized for a long-range coupling constant of 10 
Hz.24, 27 
Materials and general experimental
All reagents used were purchased from Fluorochem, Millipore, Sigma, Alpha Aeser, VWR 
International, Thermo Fisher Scientific, Qiagen, and Bio-Rad Laboratories, Inc. Ultrapure 
water (18 MΩ) was used to make buffers and solutions unless stated otherwise. All solvents 
were of HPLC grade. ULTRA PURE AccuGelTM 29:1, 30 (w/v) 29:1 acrylamide: bis-
acrylamide solution (gas stabilised) was used to make SDS-PAGE gels.  PBS refers to 
phosphate buffered saline: 1.8 mM monopotassium phosphate, 10 mM disodium phosphate, 
2.7 mM potassium chloride, 137 mM sodium chloride, pH 7.4. PierceTM BCA protein assay 
kit, and Bio-Rad Bradford protein assay was used to estimate proteins. Thermo Scientific 
SuperSignalTM West Pico PLUS chemiluminescent substrate was used to develop blotted 
membranes.  Sigma-Aldrich Medium 199 with Earle′s salts, sodium bicarbonate, phenol red, 
and without L-glutamine was used to culture 16HBE14o-. Gibco RPMI medium 1640 (1X), 
without L-glutamine was used to culture Jurkat cells. Gibco low endotoxin heat-inactivated 
foetal bovine serum was used to supplement media. Sigma-Aldrich Penicillin-Streptomycin; 
10,000 units penicillin/mL and 10 mg streptomycin/mL was used to supplement media. 
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Sigma-Aldrich 200 mM L-Glutamine solution was used to supplement media. Sigma-Aldrich 
trypsin from bovine pancreas was used to trypsinize proteins. Sigma Trypsin-EDTA solution 
(1 ×, sterile; sterile-filtered, BioReagent, suitable for cell culture, 0.5 g porcine trypsin and 
0.2 g EDTA  4Na per liter of Hanks′ Balanced Salt Solution with phenol red) was used to 
trypsinize adhered 16HBE14o- cells. Roche complete protease inhibitor cocktail was used. 
Sigma-Aldrich myoglobin from equine heart was used. Sigma-Aldrich Gelatin from cold 
water fish skin was used.  New England Biolabs pre-stained protein standard, broad Range 
(11-190 kDa) was used. Abcam pHis (ab2317090) at 1/1000 (v/v) dilution, Invitrogen pTyr 
(pY99) at 1/2000 (v/v) antibody dilution, Qiagen pThr (Q7) 1/200-1/2000 (v/v) antibody 
dilution, and Qiagen pSer (Q5) at 1/200-1/2000 antibody dilution, phospho antibodies were 
used. Dako rabbit anti-goat at 1/2000 (v/v) dilution, Dako mouse anti-rabbit at 1/2000 (v/v) 
dilution, and Abcam goat anti-Mouse IgG H&L (ab97023) at 1/10000 (v/v) dilution, 
immunoglobulins/ horseradish peroxidase were used as the secondary antibodies. Millipore® 
PVDF membranes (0.45 µm) were used to blot proteins. Silica gel 40-60 µm from VWR 
International was used. Merck TLC Silica gel 60 F254 TLC plates were used, and compounds 
were visualized by UV light (254 nm), 5 % (wt/v) ninhydrin in methanol. Sartorius Vivaspin 
20 (3 and 10 kDa MWCO) were used for dialysis and concentration of protein solutions.  
Western blotted membranes were visualised using a Bio-Rad ChemiDocTM XRS+ with image 
LabTM software. Infrared spectra were recorded using a Perkin Elmer Paragon 100 FTIR 
Spectrophotometer by attenuated total reflectance (ATR). Only selected peaks are reported, 
and the absorption maxima are given to the nearest wavenumber (cm-1). pSer, pThr, pTyr, π-
pHis, τ-pHis, and inorganic phosphate NMR spectra were recorded at room temperature. 1H 
NMR spectra were recorded using a Bruker AVANCE 400 spectrometer operating at 400.13 
MHz, or Bruker AVANCE III HD 400 spectrometer operating at 400.23 MHz. 13C NMR 
spectra were recorded using a Bruker AVANCE 400 spectrometer operating at 100.61 MHz, 
or Bruker AVANCE III HD 400 spectrometer operating at 100.64 MHz. 31P NMR spectra 
were recorded using a Bruker AVANCE III HD 400 spectrometer operating at 162.02 MHz. 
Chemical shifts were measured relative to the residual solvent and expressed in parts per 
million (δ). The multiplicities are defined as s = singlet, d = doublet, t = triplet, q= quartet, 
quint. = quintet, sex. = sextet, m = multiplet, br = broad.. High-resolution mass spectra were 
measured using an Agilent Technologies 653 Accurate-Mass Q-TOF LC/MS operating in 
electrospray mode. 
Synthesis of amino(potassiooxy)phosphinic acid (Potassium phosphoramidate). To a 
stirred mixture of water (100 mL), and 32 % (wt/wt) ammonia (50 mL), ice cold 
phosphorus(V) oxychloride (15.1 g, 9.2 mL, 98.5 mmol, 1.0 equiv.) was added dropwise at 4 
ºC, over 25 minutes. Effervescence was observed and the solution was stirred for a further 15 
minutes. Acetone (500 mL) was added and the mixture was vigorously stirred for 5 minutes. 
The aqueous layer was partitioned and acidified with glacial acetic acid to pH 6. A precipitate 
was observed. After keeping the suspension at -20 °C for 60 minutes, the precipitate was 
filtered off and washed sequentially with ethanol (20 mL) and diethyl ether (20 mL). The air-
dried crystals were added in small portions to 50 % (wt/v) potassium hydroxide (23 mL), and 
then heated to 60 °C for 20 minutes. The mixture was allowed to cool to room temperature 
and then acidified with glacial acetic acid to pH 6. The suspension was poured into ethanol 
(1150 mL) and left to stand at room temperature for 60 minutes. The precipitate was collected 
on a sintered funnel and washed sequentially with ethanol (2 x 30 mL) and diethyl ether (2 x 
30 mL) and dried under reduced pressure. Potassium phosphoramidate (6.21 g, 47 %) white 
powder: νmax(thin film)/cm-1 2849, 2473, 2175, 1614, 1462, 1413, 1150, 1073; 31P NMR 
(162 MHz, D2O) -3.33. The characterization data are comparable to the literature.49
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Synthesis of 2-amino-3-(3-phosphonoimidazol-4-yl)propanoic acid (π-pHis). L-Histidine 
(0.251 g, 1.62 mmol, 1.0 equiv.), potassium phosphoramidate (0.57 g, 4.21 mmol, 2.6 equiv.) 
and water (4.5 mL) were stirred at 25 ° C for 40 minutes. π-pHis was chromatographically 
purified see (§) for detailed procedure. The combined product fractions were concentrated by 
rotary evaporation at 25 °C to approximately 4 mL whilst maintaining a pH between 10-12 
using 2 M sodium hydroxide and 1 M hydrochloric acid. The remaining solution was 
aliquoted and snap frozen and stored at -80 °C. The concentration of π-pHis was determined 
to be 2.2 mg/mL by 1H NMR using 1,4-dioxane (0.001 g, 1 µL, 0.012 mmol) as the standard. 
π-pHis (0.0084 g, 2 % yield): RF = 0.44 (65:8:22 EtOH/32 % (wt/wt) NH3/H2O); 1H NMR 
(400 MHz) 2.96 (dd, J = 8.0, 15.5 Hz, 1H), 3.19 (dd, J = 5.0, 15.5 Hz, 1H), 3.84-3.90 (m, 
1H), 6.72 (s, 1H), 7.73 (s, 1H); 13C NMR (101 MHz) 30.6 (s), 55.3 (s), 126.2 (d, J = 8.0 Hz), 
130.4 (d, J = 3.5 Hz), 140.4 (d, J = 5.0 Hz), 181.9 (s); 31P NMR (162 MHz) - 5.61; m/z 
(ESI+): 236.0431 (MH+, 100 % C6H11N3O5P requires 236.0400). The characterization data 
are comparable to the literature.23
Synthesis of 2-amino-3-(1-phosphonoimidazol-4-yl)propanoic acid (τ-pHis). L-Histidine 
(0.251 g, 1.62 mmol, 1.0 equiv.), potassium phosphoramidate (0.57 g, 4.21 mmol, 2.6 equiv.)  
and water (4.5 mL) were stirred at 25 ° C for 16 hours. τ-pHis was chromatographically 
purified, see (§) for detailed procedure. The combined product fractions were concentrated by 
rotary evaporation at 25 °C to approximately 8 ml whilst maintaining a pH between 10-12 
using 2 M sodium hydroxide and 1 M hydrochloric acid. The remaining solution was 
aliquoted and snap frozen and stored at -80 °C. The concentration of τ-pHis was determined 
to be 4.9 mg/mL by 1H NMR against 1,4-dioxane as the standard. τ-pHis (0.103 g, 27 % 
yield): RF = 0.40 (65:8:22 EtOH/32 % (wt/wt) NH3/H2O); 1H NMR (400 MHz) 2.53 (dd, J = 
9.0, 14.5 Hz, 1H), 2.79 (dd, J = 4.5, 14.5 Hz, 1H), 3.32-3.38 (m, 1H), 6.86 (s, 1H), 7.56 (s, 
1H); 13C NMR (101 MHz) 32.6 (s), 56.0 (s), 117.8 (d, J = 5.5 Hz), 137.0 (d, J = 8.5 Hz), 
139.0 (d, J = 5.0 Hz), 181.2 (s); 31P NMR (162 MHz) - 4.78; m/z (ESI+): 236.0431 (MH+, 
100 % C6H11N3O5P requires 236.0400). The characterization data are similar to the 
literature.23
§ The following flash chromatography procedure was carried out at 4 °C and a positive 
pressure of 0.68 atmospheres. The sample was loaded on to a pre-equilibrated (85:4:1 
ethanol/32 % (wt/wt) ammonia/water) silica gel column (4 cm diameter column with 27 cm 
of silica) and eluted with a mixture of ethanol, 32 % (wt/wt) ammonia and water gradient. 
(Initially 300 mL of an 85:4:1 mixture was added: once 150 mL was eluted, 150 mL of a 
75:4:10 mixture was added. After a further 150 mL was eluted an additional 150 mL of this 
solvent was added. Subsequently the same cycle was repeated with solvent mixture ratio of 
70:4:15 (300 mL), and 60:4:25, (300 mL) until the compound was eluted). The first 750 mL 
was run off and 15 mL fractions were collected. The product fractions were collected such 
that 5 fractions between the product and the first (for π-pHis) and last (π-pHis) co-eluted π- 
and τ-pHis mixture were discarded as analysed by TLC.
Synthesis of phosphorylated myoglobin (Myo-pHis), and dialysis
Dialysis buffer: 0.1 M sodium carbonate/bicarbonate, pH 10.8.
Myoglobin from equine heart (50 mg, 2.8 µM, 1 equiv.) was dissolved in water (4.5 mL). 
Potassium phosphoramidate (0.61 g, 4.5 mmol, 1585 equiv.) was added and the mixture was 
stirred at 25 ºC for 15 hours. The mixture was added to a Vivaspin 20 (10 kDa, MWCO) and 
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concentrated down to ~1 mL by centrifugation (6 °C, 3220 RCF). The solution was made up 
to 5 mL with dialysis buffer and the solution was again concentrated down to ~1 mL as 
described above; this step was repeated 7 times. The sample was made up to 2 mL using 
dialysis buffer. The Myo-pHis protein concentration was determined by Bradford assay and 
myoglobin was used to generate the standard curve. 10 % (v/v) D2O was added to the Myo-
pHis solution and analysed by 31P NMR spectroscopy. The sample was stable for weeks at 4 
°C and could be snap frozen and stored at 80 °C (freeze thaw cycles were avoided).  For 31P 
NMR spectroscopy of denatured Myo-pHis, urea (210 mg) was added to the Myo-pHis (500 
µL) solution followed by D2O (50 µL) before analysis. 
Acid treatment of Myo-pHis
The pH of Myo-pHis was reduced to ~pH 4 using glacial acetic acid and it was then heated at 
90 °C for 45 min. A precipitate was observed. Sodium carbonate (10 mg) and sodium 
hydrogen carbonate (1 mg) was added. To help dissolve the precipitate, urea (210 mg) and 
ethylenediaminetetraacetic acid disodium salt dihydrate (9 mg) were added and left 
overnight. 10 % (v/v) D
2




Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Resolving gel: 12 % (wt/v) acrylamide, 0.1 % (w/v) sodium dodecyl sulfate, 0.1 % (w/v) 
ammonium persulphate, 0.001 % (v/v) tetramethylenediamine, 0.38 M 
tris(hydroxymethyl)aminomethane-hydrochloride, pH 8.8.
Stacking gel: 4% (wt/v) acrylamide, 0.1 % (w/v) sodium dodecyl sulfate, 0.1 % (w/v) 
ammonium persulphate, 0.001 % (v/v) tetramethylenediamine, 0.125 
Mtris(hydroxymethyl)aminomethane-hydrochloride, pH 8.8.
Freshly prepared resolving gel solution was immediately poured between 10 cm  10 cm (1 
mm spacers) and 10 cm  10 cm (notched) glass plates. Isopropanol (~200 µL) was slowly 
added to the top. The gel was left to polymerise at room temperature for 30 minutes. The 
isopropanol was poured away, and the top of the gel was washed with water ( 3). Excess 
water was soaked up with a filter paper. Freshly prepared stacking gel (pH 8.8) solution was 
poured over the resolving gel to fill the cavity. A 10 well comb (~30 µL capacity per well) 
was inserted and the gel was allowed to form at room temperature for 2 hours. Gels were 
used immediately or stored in plastic with a damp (running buffer) tissue for up to 3 days. 
Culturing of human bronchial epithelial (16HBE14o- or HBE) cell line 
Full serum medium: Medium 199, supplemented with 10 % (v/v) fetal bovine serum, 1.3 mM 
of L-glutamine, 80 µg/mL streptomycin, 80 units/mL penicillin.
16HBE14o- cell line was cultured in 57 cm2 dishes in full serum medium (10 mL) and 
incubated at 37 ºC in a 5 % CO2 atmosphere. The medium was changed every 2-3 days by 
discarding the old medium, washing the cells with PBS (3 mL) and then replacing with fresh 
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full serum medium (10 mL). Once the 16HBE14o- cells were between 70-90 % confluency, 
they were split or harvested.
Culturing of Jurkat cell line
Full serum medium: RPMI medium 1640, supplemented with 10 % (v/v) fetal bovine serum, 
1.3 mM of L-glutamine, 100 µg/mL streptomycin, 100 units/mL penicillin.
Jurkat cells were cultured in T75 flasks in full serum medium (30 mL) and incubated at 37 ºC 
in a 5 % CO2 atmosphere. The cells were harvested or split 1:3 once cell densities of 1 × 106 
cell/mL were reached.
 
Lysis of 16HBE14o- and Jurkat cells for Western blots
Western blot lysis buffer: 150 mM sodium chloride, 0.5 % (wt/v) sodium deoxycholate, 1 % 
(v/v) Triton X-100, 0.1 % (wt/v) sodium dodecyl sulfate, 10 mM sodium fluoride, 5 mM 
sodium orthovanadate, 10 mM sodium pyrophosphate, complete protease inhibitor, 50 mM 
tris(hydroxymethyl)aminomethane-hydrochloride, pH 8.8.
For preparation of 16HBE14o- cell lysate for Western blots, media from 57 cm2 cell culture 
dishes with adherent 16HBE14o- cells was discarded and the cells were washed with PBS (5 
mL). The cell culture dish was cooled on ice and any residual PBS was discarded. Cells were 
scraped into ice cold lysis buffer (100 µL). After centrifugation (4 ºC, 8950 RCF, 1 min), the 
supernatant was taken and used immediately or snap frozen and used within 3 days.  
For preparation of Jurkat cells for Western blots, cell suspension (10-14 million cells total) 
were centrifuged (room temp., 453 RCF, 10 min). The supernatant was discarded, and the 
cells were suspended in PBS (5 mL). After centrifugation (room temp., 453 RCF, 10 min) the 
supernatant was discarded, and the cells were cooled on ice. Ice-cold lysis buffer (100 µL) 
was added and the mixture was agitated by vortexing before centrifugation (4 ºC, 8950 RCF, 
1 min). The supernatant was taken and used immediately or snap frozen and used within 3 
days.  
Western blot 
5 (concentrated) sample buffer: 10 % (wt/v) lithium dodecyl sulfate, 40 % (wt/v) glycerol, 
0.02 % (wt/v) bromophenol blue, 50 mM ethylenediaminetetraacetic acid disodium salt 
dihydrate, 500 mM dithiothreitol, 300 mM tris(hydroxymethyl)aminomethane-hydrochloride, 
pH 9.0. 1 sample buffer was made by diluting 5 sample buffer in water.
Resolving buffer: 0.1 % (w/v) sodium dodecyl sulfate, 192 mM Glycine, 25 mM 
tris(hydroxymethyl)aminomethane, pH 8.3.
Transfer buffer: 192 mM glycine, 25 mM tris(hydroxymethyl)aminomethane, pH 8.3.
Wash buffer: 165 mM sodium chloride, 0.05 % (v/v) Tween 20, 10 mM 
tris(hydroxymethyl)aminomethane-hydrochloride, pH 8.0.
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Blocking buffer: 0.2 % (v/v) gelatin from cold water fish skin, 165 mM sodium chloride, 0.05 
% (v/v) Tween 20, 10 mM tris(hydroxymethyl)aminomethane-hydrochloride, pH 8.0.
Protein samples were treated with 5 sample buffer to give a 1 final concentration and then 
made up to 30 µL with 1 sample buffer. The samples were left at room temperature for 15 
minutes and then loaded in to the SDS-PAGE gel wells. The samples were resolved using 
resolving buffer with the tank immersed in ice, at 120 V for the first 10 minutes and then 180 
V for 50-60 minutes. The resolved proteins were immediately electro blotted onto a methanol 
activated PVDF membrane using transfer buffer with the tank immersed in ice at 100 V for 1 
hour. The following steps were carried out at room temperature. Blocking buffer (75 mL) was 
added over the membrane (~8  8 cm) in a covered tray (10 cm  14 cm) and left for 1 hour 
on an orbital shaker. The solution was discarded. The membrane and primary antibody 
diluted in blocking buffer (10 mL) was added to a centrifuge vial (50 mL) and left for 1 hour 
on a tube roller. The solution was discarded, and the membrane was put back in the tray on an 
orbital shaker and washed (6  5 min) with wash buffer (50 mL). The membrane and 
secondary antibody diluted in blocking buffer (10 mL) were added to a centrifuge vial (50 
mL) and left for 1 hour on a tube roller. The solution was discarded, and the membrane was 
put back in the tray on an orbital shaker and washed (6  5 min) with wash buffer (50 mL). 
The membrane was then incubated in chemiluminescence solution for 1 minute. After 
draining off the excess chemiluminescence solution, the membrane was imaged.
Trypsinization of Myo-pHis and desalting under typical conditions
The method followed Chen et al.21 with minor changes. 
Dialysis buffer: 0.1 M ammonium bicarbonate, pH 8.0.
Myo-pHis (20 mg) was buffer exchanged (3 cycles of buffer exchange) into dialysis buffer 
using a Vivaspin 20 (3 kDa MWCO) and made up to 1 mL. 1/50 (wt/wt) trypsin was added 
and the mixture was shaken (600 rpm) at 37 ° C for 16 hours. To half of the mixture (~ 500 
µL), sodium carbonate (10 mg), sodium hydrogen carbonate (1 mg), and D2O (50 µL) was 
added and analyzed by 31P NMR spectroscopy. 
A C-18 resin Sep-Pak cartridge (130 mg) was conditioned sequentially with acetonitrile (2.6 
mL), 50 % (v/v) acetonitrile, 0.1 % trifluoroacetic acid (2.6 mL) and 0.1 % trifluoroacetic 
acid (2.6 mL). The remaining sample (~500 µL) was made up to 2 mL using water. Half of 
the sample (1 mL) was acidified to pH 3 using aqueous 10 % (v/v) trifluoroacetic acid and 
passed through the cartridge. The flow through was collected and passed through the 
cartridge again; this step was repeated once more.  The resin was washed with 0.1 % (v/v) 
trifluoroacetic acid (2.6 mL), and then extracted with 50 % (v/v) acetonitrile, 0.1 % (v/v) 
trifluoroacetic (0.6 mL). The other half of the sample (1 mL) was desalted in the same way 
using a fresh cartridge. The solvent from the combined fractions was removed under reduced 
pressure. The remaining residue was solubilized in 0.1 M sodium carbonate/hydrogen 
carbonate, pH 10.8 (500 µL), and analyzed by 31P NMR spectroscopy after the addition of 
D2O (50 µL).     
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Trypsinization of Myo-pHis and desalting under milder conditions
The method followed Hardman et al.12 with minor changes. 
Dialysis buffer: 0.1 M ammonium bicarbonate, pH 8.0.
Myo-pHis (20 mg) was buffer exchanged (3 cycles of buffer exchange) into dialysis buffer 
using a Vivaspin 20 (3 kDa MWCO) and made up to 1 mL. The sample was treated with 
dithiothreitol (7 mM) and shaken (600 rpm) at 30° C for 20 minutes. After allowing the 
mixture to cool to room temperature, iodoacetamide (14 mM) was added and the mixture was 
left in the dark at room temperature.  Dithiothreitol (3 mM) was added followed by 2 % 
(wt/wt) trypsin and the mixture was shaken (600 rpm) at 30 ° C for 16 hours. To half of the 
mixture (~ 500 µL), sodium carbonate (10 mg), sodium hydrogen carbonate (1 mg), and D2O 
(50 µL) was added and analysed by 31P NMR spectroscopy. 
A C-18 resin Sep-Pak cartridge (130 mg) was conditioned sequentially with methanol (2.6 
mL), 50 % (v/v) acetonitrile (2.6 mL) and water (2.6 mL). The remaining sample (~500 µL) 
was made up to 2 mL using water and half of the sample (1 mL) was passed through the 
cartridge. The flow through was collected and passed through the cartridge again; this step 
was repeated once more.  The resin was washed with water (2.6 mL), and then extracted with 
50 % (v/v) acetonitrile (0.6 mL). The other half of the sample (1 mL) was desalted in the 
same way using a fresh cartridge. Both desalted samples were combined and solvent was 
removed under reduced pressure. The remaining residue was solubilized in 0.1 M sodium 
carbonate/hydrogen carbonate, pH 10.8 (500 µL), and analysed by 31P NMR spectroscopy 
after the addition of D2O (50 µL).                 
Preparation of proteins from the 16HBE14o- and Jurkat cell lysate for 31P NMR 
spectroscopy
The lysis and dialysis procedure was done as quickly as possible.  
Lysis buffers: 16HBE14o- cells were lysed in 0.1 M sodium carbonate/bicarbonate, 7 M urea, 
pH 10.8. 
Full serum medium: Medium 199 (including phenol red), supplemented with 10 % (v/v) fetal 
bovine serum, 1.3 mM of L-glutamine, 80 µg/mL streptomycin, 80 units/mL penicillin.
Dialysis buffer: 7 M urea, 0.1 M sodium carbonate/bicarbonate, pH 10.8.
The medium was removed from five cell culture dishes (57 cm2) containing adhered 
16HBE14o- cells between 70-90 % confluent. The medium was discarded, and the cells were 
washed with PBS (10 mL). The petri dishes were cooled on ice and care was taken to remove 
as much PBS as possible. Ice cold lysis buffer (150 µL) was added to each petri dish. Each 
petri dish was carefully shaken to evenly spread the lysis buffer. The cells were scraped into 
the lysis buffer and the lysate from each dish was transferred to another vial on ice. The lysis 
procedure was repeated three more times for a total of twenty cell culture dishes. For a cell 
count, five petri dishes were taken, and the cells were washed as described above. See (‖) 
below for cell count procedure.  The combined cell lysate was sonicated on ice (45% 
amplitude 10  5 sec bursts, 59 sec rest between each burst). The lysate (~ 6 mL) was added 
to a Vivaspin 20 protein concentrator spin column (3 kDa MWCO) and concentrated down to 
~1.5 mL by centrifugation (6 °C, 3220 RCF, ~2.5 hr). 1 mL dialysis buffer was added, and 
the mixture was concentrated down as above to ~ 1.5 mL. This step was repeated 14 times. 
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The sample finally was concentrated down to ~0.5 mL. 10 % (v/v) D2O was added to a 
portion of this sample which was analysed by 31P NMR spectroscopy (for quantitative 
analysis 300 µL was used to accommodate the capillary containing the external standard). 
The 16HBE14o- cell lysate protein concentration was quantified by BCA assay, using BSA 
to generate the standard curve. The sample was stable for weeks at 4 °C and could be snap 
frozen and stored at 80 °C (freeze thaw cycles were avoided).  
(‖) Each dish was treated with 2 mL of trypsin, at 37 ºC for 7 minutes. A cell scraper was 
used to help dislodge any weakly adhered cells. The cells in each petri dish were diluted with 
full serum medium to give a total volume of 10 mL and transferred to a separate vial. In a 
triplicate cell count, 10 µL was taken from each cell suspension to determine the average cell 
count using a hemocytometer. The average cell count of each cell suspension was then 
averaged between the five separate samples, to give an average cell count.
Jurkat cell (~240 × 106 cells) were pelleted by centrifugation (room temp., 207 RCF, 10 min) 
and the supernatant was discarded. The cells were washed with PBS (10 mL) and the 
centrifugation cycle was repeated. The cells were lysed on ice using lysis buffer (6 mL) and 
prepared for 31P NMR analysis as described above.
Trypsinization of proteins from 16HBE14o- cell lysate and desalting under typical 
conditions
The method followedChen et al.21 with minor changes. 
Dialysis buffer: 0.1 M ammonium bicarbonate, pH 8.0.
The prepared 16HBE14o- cell lysate (sample volume used in the previous 31P NMR 
spectroscopy step) was diluted with 1 mL of dialysis buffer and added to a Vivaspin 20 
protein concentrator spin column (3 kDa MWCO) and concentrated down to ~1.0 mL by 
centrifugation (6 °C, 3220 RCF). Dialysis buffer (1mL) was added, and again the mixture 
was concentrated down to ~ 1.0 mL as described above. This step was repeated 3 times. The 
mixture was concentrated down to the starting sample volume and 1/50 (wt/wt) trypsin was 
added. Once the trypsin had dissolved, the solution was mixed using an Eppendorf 
Thermomixer (600 rpm) at 37 ºC for 16 hours. The sample was divided in two and to one half 
of the sample sodium carbonate (5 mg), sodium bicarbonate (0.5 mg) and 10 % (v/v) D2O 
was added and analysed by 31P NMR spectroscopy. 
A C-18 resin Sep-Pak cartridge (130 mg) was equilibrated with acetonitrile (2.6 mL) 
followed by aqueous 50 % (v/v) acetonitrile + 0.1 % (v/v) trifluoroacetic acid (1.5 mL) and 
finally aqueous 10 % (v/v) trifluoroacetic acid. Trypsinized proteins from 16HBE14o- cell 
lysate were made up to 1 mL using water. The sample was acidified to pH 3 using aqueous 
10 % (v/v) trifluoroacetic acid and passed through the equilibrated Sep-Pak cartridge. The 
flow through was collected and passed through the cartridge again, this step was repeated 
once more. The resin was washed with ice cold ultrapure water (2.6 mL) and the peptides 
were eluted from the resin using aqueous 50 % (wt/wt) acetonitrile (600 µL). The solvent was 
removed by speed vac at room temperature and the remaining residue was solubilized in 0.1 
M carbonate/bicarbonate, pH 10.8 (same as starting volume) and analyzed by 31P NMR 
spectroscopy after the addition of 10 % (v/v) D2O.
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Trypsinization of proteins from the 16HBE14o- cell lysate and desalting under milder 
conditions
The method followed Hardman et al.12 with minor changes. 
Lysis buffer: 50 mM ammonium bicarbonate, 8 M urea, complete protease inhibitor cocktail, 
pH 8.0.
The medium was removed from five cell culture dishes (57 cm2) containing adhered 
16HBE14o- cells between 70-90 % confluent. The medium was discarded, and the cells were 
washed with PBS (10 mL). The petri dishes were cooled on ice and care was taken to remove 
as much PBS as possible. Ice cold lysis buffer (150 µL) was added to each petri dish. Each 
petri dish was carefully shaken to evenly spread the lysis buffer. The cells were scraped into 
the lysis buffer and the lysate from each dish was transferred to another vial on ice. The lysis 
procedure was repeated once more for a total of 10 cell culture dishes. The combined cell 
lysate was sonicated on ice (35 % amplitude 10  5 sec bursts, 59 sec rest between each 
burst). The lysate was treated with dithiothreitol (7 mM) and shaken (600 rpm) at 30° C for 
20 minutes. After allowing the mixture to cool to room temperature, iodoacetamide (14 mM) 
was added and the mixture was left in the dark at room temperature.  Dithiothreitol (3 mM) 
was added and the mixture was diluted to 2 M urea using 50 mM ammonium bicarbonate, pH 
8.0. 2 % (wt/wt) trypsin was added and the mixture was shaken (600 rpm) at 30 ° C for 16 
hours. A C-18 resin Sep-Pak cartridge (130 mg) was conditioned sequentially with methanol 
(2.6 mL), 50 % (v/v) acetonitrile (2.6 mL) and water (2.6 mL). The remaining sample (~500 
µL) was made up to 2 mL using water and half of the sample (1 mL) was passed through the 
cartridge. The flow through was collected and passed through the cartridge again; this step 
was repeated once more.  The resin was washed with water (2.6 mL), and then extracted with 
50 % (v/v) acetonitrile (0.6 mL). The other half of the sample (1 mL) was desalted in the 
same way using a fresh cartridge. Both desalted samples where combined and solvent was 
removed under reduced pressure. The remaining residue was solubilized in 0.1 M sodium 
carbonate/hydrogen carbonate, pH 10.8 (500 µL) and analysed by 31P NMR spectroscopy 
after the addition of 10 % (v/v) D2O.                 
DNA extraction and precipitation of proteins from the 16HBE14o- cell lysate
The method followed Antonioli et al. with slight modifications.38
Lysis buffers: 30 mm tris(hydroxymethyl)aminomethane-hydrochloride, 50 mm sodium 
chloride, complete protease inhibitor, pH 9.0.
Dialysis buffer: 8 M urea, 0.1 M sodium carbonate/bicarbonate, pH 10.8.
DNA extraction solution: phenol/chloroform/isoamyl alcohol (25:24:1).
Lysed 16HBE14o- cells (700 µL, 18.1 mg of protein) were sonicated on ice (45% amplitude 
10  5 sec bursts, 59 sec rest between each burst). The pH was raised to pH 10 using 2 M 
NaOH. The lysate was centrifuged to pellet any debris. The supernatant was removed and 
DNA extraction solution (1.4 mL) was added. The mixture was vortexed and left on ice for 5 
minutes and then centrifuged (4 °C, 17000 RCF, 10 min). The upper aqueous and the bottom 
organic phase were carefully removed.  Acetone (3ml) was added to the remaining 
precipitate. The precipitate was centrifuged, and the supernatant was removed. The 
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precipitate was allowed to air dry and then solubilized in in dialysis buffer (1.5 ml). The 
mixture was added to a Vivaspin 20 protein concentrator spin column (3 kDa MWCO) and 
concentrated down to ~ 1.0 mL by centrifugation (6 °C, 3220 RCF, ~2.5 hr). 1 mL dialysis 
buffer was added, and the mixture was concentrated down as above to ~ 1.0 mL. This step 
was repeated 7 times. The sample was concentrated down to ~ 0.5 mL and 10 % (v/v) D2O 
was added before analysis by 31P NMR spectroscopy.
.
Precipitation of proteins from the 16HBE14o- cell lysate
The method followed Potel et al.,13 with minor modification.
Lysed cells were prepared as described in “Preparation of proteins from the 16HBE14o- and 
Jurkat cell lysate for 31P NMR spectroscopy”. Total lysate volume after sonication: 6.5 mL. 
Methanol (13 mL), chloroform (3.3 mL), and water (10 mL) were sequentially added to the 
lysate and followed by vigorous vortexing after the addition of each solution. The mixture 
was centrifuged (6 °C, 3220 RCF, 10 min) and the upper layer was discarded. Methanol (10 
mL) was added and the mixture was vortexed and then centrifuged (6 °C, 3220 RCF, 10 
min). The supernatant was discarded. The precipitate was dissolved in 0.1 M sodium 
carbonate/bicarbonate, pH 10.8 and 10 % (v/v) D2O was added before 31P NMR 
spectroscopy. 
Chemical phosphorylation
Dialysis buffer: 8 M urea, 0.1 M sodium carbonate/bicarbonate, pH 10.8.
The proteins from the 16HBE14o- cells prepared from the “DNA extraction” procedure (500 
µL) were treated with potassium phosphoramidate (68 mg, 0.5 mmol). The mixture was 
turned end over end at room temperature for 15 minutes. Dialysis buffer (400 µL) and water 
(200 µL) was added and the mixing was continued at room temperature for a further 1 hour. 
The mixture was made up to 3.5 mL with dialysis buffer.  The mixture was added to a 
Vivaspin 20 protein concentrator spin column (3 kDa MWCO) and concentrated down to ~ 
1.5 mL by centrifugation (6 °C, 3220 RCF, ~2.5 hr). 1 mL dialysis buffer was added, and the 
mixture was concentrated down as above to ~ 1.5 mL. This step was repeated 7 times. The 
sample finally was concentrated down to ~ 0.5 mL and 10 % (v/v) D2O was added before 
analysis by 31P NMR spectroscopy.
Acid treatment of proteins from the 16HBE14o- cell lysate
The pH of proteins from the 16HBE14o- cell lysate in 91 mM sodium carbonate/bicarbonate, 
6.4 M urea, 10 % (v/v) D2O was reduced to ~pH 4 using glacial acetic acid and it was then 
heated at 90 °C for 45 min. A precipitate was observed. Sodium carbonate (10 mg) and 
sodium hydrogen carbonate (1 mg) was added. 10 % (v/v) D
2
O was added to the sample 
before analysis by 
31
P NMR spectroscopy.
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